AMB-CHMINACA
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H29N3O3 |
Molar mass | 371.481 g·mol−1 |
3D model (JSmol) | |
| |
|
AMB-CHMINACA or MMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid[1] that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.[2][3][4]
Legal status
AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[5]
Sweden's public health agency classified AMB-CHMINACA as a narcotic substance, on January 18, 2019.[6]
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.